Search research articles
Contact Us
Filters
Showing results (61-70 of 242) with videos related to
Page
of 25
Sort By:
Experimental Neurology
|
November 5, 2003
mGluRs: a target for pharmacotherapy in Parkinson disease
Jennifer A Feeley Kearney, Roger L Albin
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 5, 2011
Treating mouse models of Huntington disease
Sara J Tallaksen-Greene, Roger L Albin
Eneuro
|
August 10, 2017
Normal Striatal Vesicular Acetylcholine Transporter Expression in Tourette Syndrome
Roger L Albin, Christine Minderovic, Robert A Koeppe
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 26, 2026
The Dark Matter of Levodopa Pharmacodynamics
Roger L Albin, Daniel K Leventhal, Philipp Mahlknecht
JAMA
|
July 16, 2002
Brain imaging to assess the effects of dopamine agonists on progression of Parkinson disease
Roger L Albin, Thomas E Nichols, Kirk A Frey
Experimental Neurology
|
May 9, 2014
Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function
Martin Sarter, Roger L Albin, Aaron Kucinski, et al.
Epilepsy & Behavior : E&B
|
July 22, 2020
Seizure occurrence and related mortality in dementia with Lewy bodies
Rohit Marawar, Nicole Wakim, Roger L Albin, et al.
Neurobiology of Disease
|
July 22, 2008
Rodent genetic models of Huntington disease
Mary Y Heng, Peter J Detloff, Roger L Albin
Behavioural Brain Research
|
January 18, 2015
Modeling falls in Parkinson's disease: Slow gait, freezing episodes and falls in rats with extensive striatal dopamine loss
Aaron Kucinski, Roger L Albin, Cindy Lustig, et al.
Experimental Neurology
|
March 10, 2005
Genetics of subthalamic nucleus in development and disease
Steven T Philips, Roger L Albin, Donna M Martin
Page
of 25
Search research articles
Search
Showing results (61-70 of 242) with videos related to
Sort By:
Page
of 25
Experimental Neurology
|
November 5, 2003
mGluRs: a target for pharmacotherapy in Parkinson disease
Jennifer A Feeley Kearney, Roger L Albin
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 5, 2011
Treating mouse models of Huntington disease
Sara J Tallaksen-Greene, Roger L Albin
Eneuro
|
August 10, 2017
Normal Striatal Vesicular Acetylcholine Transporter Expression in Tourette Syndrome
Roger L Albin, Christine Minderovic, Robert A Koeppe
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 26, 2026
The Dark Matter of Levodopa Pharmacodynamics
Roger L Albin, Daniel K Leventhal, Philipp Mahlknecht
JAMA
|
July 16, 2002
Brain imaging to assess the effects of dopamine agonists on progression of Parkinson disease
Roger L Albin, Thomas E Nichols, Kirk A Frey
Experimental Neurology
|
May 9, 2014
Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function
Martin Sarter, Roger L Albin, Aaron Kucinski, et al.
Epilepsy & Behavior : E&B
|
July 22, 2020
Seizure occurrence and related mortality in dementia with Lewy bodies
Rohit Marawar, Nicole Wakim, Roger L Albin, et al.
Neurobiology of Disease
|
July 22, 2008
Rodent genetic models of Huntington disease
Mary Y Heng, Peter J Detloff, Roger L Albin
Behavioural Brain Research
|
January 18, 2015
Modeling falls in Parkinson's disease: Slow gait, freezing episodes and falls in rats with extensive striatal dopamine loss
Aaron Kucinski, Roger L Albin, Cindy Lustig, et al.
Experimental Neurology
|
March 10, 2005
Genetics of subthalamic nucleus in development and disease
Steven T Philips, Roger L Albin, Donna M Martin
Page
of 25